Latest return on equity
Neumora Therapeutics Return on equity
Direct answer
Neumora Therapeutics's return on equity is -187.11%.
The verified market snapshot reports -187.11%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 19, 2026.
Get free Neumora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -187.11%
Explore related company data
View Neumora Therapeutics's market capitalizationView Neumora Therapeutics's price-to-book ratioView Neumora Therapeutics's 52-week price rangeView Neumora Therapeutics's profit marginView Neumora Therapeutics's debt-to-equity ratioView all Neumora Therapeutics key metricsReturn to Neumora Therapeutics profile